The Infusion Providers Alliance (IPA) is the leading voice for [...]
About Infusion Providers AllianceThis author has not yet filled in any details.
So far Infusion Providers Alliance has created 23 blog entries.
The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, [...]
Suspension of the Medicare sequester is key to helping providers administer critical medicines during the COVID-19 pandemic.
A new coalition of drug infusion providers has been established to advocate for policies that preserve patients’ access to infused medicines.
Infusion centers and physician offices rely on the current, well-established “buy-and-bill” distribution system that has provided uninterrupted and reliable patient access to Part B infused drugs for decades.
The Infusion Providers Alliance supports the Senate Finance Committee’s overall goals of lowering prescription drug costs for patients. However, the alliance is concerned that a coupon provision included in “The Prescription Drug Pricing Reduction Act of 2019” could increase out-of-pocket costs and make treatment less accessible